Each month, subscribers to receive 5 to 6 well-documented monographs on drugs that are newly released orare in late phase 3 trials. The monographs are targeted to Pharmacy &Therapeutics Committees. Subscribers also receive monthly 1-page summarymonographs on agents that are useful for agendas and pharmacyursingin-services. A comprehensive target drug utilization evaluation/medication useevaluation (DUE/MUE) is also provided each month. With a subscription, themonographs are available online to subscribers. Monographs can be customized tomeet the needs of a facility. Through the cooperation of publishes selected reviews in this column. Formore information about , contactWolters Kluwer customer service at 866-397-3433.
展开▼
